A new study has shown that only a minority of patients in the U.S. with type 1 diabetes achieve target levels of hemoglobin A1c, a measure of blood glucose management over time.
In fact, HbA1c levels have increased in young adults and teens in 2016-2018 compared to 2010-2012 according to the study.
In addition to reporting on HbA1c levels, in their review, the researchers discuss the utilization of diabetes technology and various aspects of diabetes management, metabolic control, and acute complication of T1D.
“Despite the availability of newer insulin analogs and increased use of insulin pumps and CGMs in the U.S., the mean A1c levels for patients with type 1 diabetes have increased in the past 5 years and only 1 out 5 patients reach ADA target A1c levels,” says Diabetes Technology & Therapeutics editor-in-chief and co-author of the article, Dr. Satish Garg. “Above all these data represent 30,000 patients followed at the leading centers in the U.S.”
You can click here to read the full-text article free on the Diabetes Technology & Therapeutics (DTT) website through February 22, 2019.
The article has been published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Fewer than half of adults and youth with type 1 diabetes in the US achieve treatment goals. 2019, Jan. 22. EurekAlert! Retrieved: https://www.eurekalert.org/pub_releases/2019-01/mali-fth012219.php